APG Asset Management
NVCR icon

APG Asset Management’s NovoCure NVCR Stock Holding History

APG Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17,750
Closed -$240K – 735
2023
Q4 		$240K Sell
17,750
-4,200
-19% -$56.2K ﹤0.01% 698
2023
Q3 		$354K Sell
21,950
-61,500
-74% -$1.77M ﹤0.01% 680
2023
Q2 		$3.17M Hold
83,450
– – 0.01% 506
2023
Q1 		$4.62M Sell
83,450
-14,045
-14% -$1.12M 0.01% 505
2022
Q4 		$7.15M Buy
+97,495
New +$7.34M 0.01% 489

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APG Asset Management's NVCR Position: Q1 2024 in Review

APG Asset Management sold out of NovoCure (NVCR) in Q1 2024, closing a stake of 17,750 shares — an estimated $240K sold.

APG Asset Management first reported a position in NVCR in Q4 2022 and held it in 5 quarters. The position peaked at $7.15M in Q4 2022. 237 funds tracked by Wall St. Rank hold NVCR as of Q1 2024.

  • APG Asset Management reported no remaining NovoCure position as of Q1 2024 after selling out during the quarter.
  • APG Asset Management sold 17,750 NovoCure shares in Q1 2024, an estimated $240K.
  • APG Asset Management first reported a position in NovoCure in Q4 2022 and held it in 5 quarters.
  • APG Asset Management's NovoCure position peaked at $7.15M in Q4 2022.
  • 237 funds tracked by Wall St. Rank held NovoCure as of Q1 2024.

Based on APG Asset Management's 13F filing for Q1 2024, filed 14 May 2024.